PFS Investments’s Zimmer Biomet ZBH Stock Holding History

PFS Investments’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$225K	Buy	+1,543	New	+$210K	﹤0.01%	480

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

PFS Investments's ZBH Position: Q2 2023 in Review

PFS Investments opened a new position in Zimmer Biomet (ZBH) in Q2 2023: 1,543 shares worth $225K. The stake represents ﹤0.01% of the portfolio and ranks #480 among its holdings.

1,030 funds tracked by Wall St. Rank hold ZBH as of Q2 2023.

PFS Investments held 1,543 shares of Zimmer Biomet worth $225K as of Q2 2023.
Zimmer Biomet was a new PFS Investments position in Q2 2023.
Zimmer Biomet made up ﹤0.01% of PFS Investments's portfolio in Q2 2023, its #480 holding.
1,030 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2023.

Based on PFS Investments's 13F filing for Q2 2023, filed 14 Aug 2023.